Last reviewed · How we verify

NCT05101473

Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study

Completed NA Last updated 10 August 2022
What this trial tests

NA trial testing Exercise Therapy in Diabetic Foot Ulcer in 3 participants. Completed in 1 April 2022.

Timeline
1 September 2021
Primary endpoint
1 April 2022
1 April 2022

Quick facts

Lead sponsorHolbaek Sygehus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment3
Start date1 September 2021
Primary completion1 April 2022
Estimated completion1 April 2022
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Holbaek Sygehus — full company profile →

Who can join

18 and older, any sex, with Diabetic Foot Ulcer or Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this feasibility study is to evaluate a 12-week exercise intervention in people with an active diabetic foot ulcer through pre-defined research progression criteria (participant recruitment and retention, duration of the collection of outcome measures, adherence to the exercise programme, and adverse events), besides participant and physiotherapist feedback, self-reported outcomes and objective measurements in preparation for a potential future RCT. The primary study hypothesis is that exercise therapy for people with an active diabetic foot ulcer will have high participant recruitment and adherence to treatment and that it does not affect wound healing negatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise Therapy

Trials testing the same drug.

Other recruiting trials for Diabetic Foot Ulcer

Currently open trials in the same condition.

Other Holbaek Sygehus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05101473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing